ASHLEY LAUER: Open Payments
NPI 1528408341 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 18 payments from 8 companies in 2025. Trend: 2023 $257 · 2024 $177 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $117 |
| Xeris Pharmaceuticals, Inc. | 1 | $98 |
| ABBVIE INC. | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Novo Nordisk Inc | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Organon LLC | 1 | $26 |
| Seqirus USA Inc | 1 | $24 |
Products named: VOQUEZNA, GVOKE HYPOPEN, Ozempic, QULIPTA, AIRSUPRA, VRAYLAR, NEXPLANON, Fluad.
Industry payments across NC — which companies pay providers there.
